---
title: "Anagram Therapeutics funding: rounds, investors, and totals | Datahyena"
url: https://datahyena.com/companies/anagram-therapeutics/
description: "Anagram Therapeutics funding history (Biotechnology Research): 1 round, $250M disclosed, with investors and dates."
---

- [Home](https://datahyena.com/)
/

- [Companies](https://datahyena.com/companies)
/

- Anagram Therapeutics

 A ![Anagram Therapeutics logo](https://img.logo.dev/anagramtx.com?token=pk_BUpIw_i4QLa-EJtl_XiDng&size=128&format=png&retina=true&fallback=404)

# Anagram Therapeutics

 Anagram Therapeutics is a biotechnology research company based in Natick, US, founded in 2023. Anagram Therapeutics is pioneering novel orally delivered enzyme therapeutics to treat serious diseases caused by malabsorption syndromes and nutrient metabolism disorders.

Total disclosed
 $250M

Rounds tracked
 1

Latest round
 Other May 7, 2026

## Funding history

 Anagram Therapeutics has one funding round on record with Datahyena: Other of $250M, announced May 7, 2026. Backers across these rounds include Blackstone, Blackstone Life Sciences. Each round is deduplicated across the outlets that reported it and resolved to canonical companies and investors.

 [$250M Other Blackstone, Blackstone Life Sciences

 May 7, 2026
→](https://datahyena.com/funding-rounds/anagram-therapeutics-other-2026-05)

Track companies like this

 Anagram Therapeutics's rounds are deduplicated across the outlets that reported them and resolved to
 canonical companies and investors. Get new rounds the moment they land, over the API or
 your agent.

 [Get your API key

→](https://app.datahyena.com/register) [Use it from your agent](https://datahyena.com/mcp)

## More biotechnology research companies

 [B ![Beeline Medicines logo](https://img.logo.dev/beelinemedicines.com?token=pk_BUpIw_i4QLa-EJtl_XiDng&size=128&format=png&retina=true&fallback=404) Beeline Medicines](https://datahyena.com/companies/beeline-medicines)[A ![ALP Bio logo](https://img.logo.dev/alp.bio?token=pk_BUpIw_i4QLa-EJtl_XiDng&size=128&format=png&retina=true&fallback=404) ALP Bio](https://datahyena.com/companies/alp-bio)[A ![ARTAN Bio logo](https://img.logo.dev/artan.bio?token=pk_BUpIw_i4QLa-EJtl_XiDng&size=128&format=png&retina=true&fallback=404) ARTAN Bio](https://datahyena.com/companies/artan-bio)[R ![Rainbow Crops logo](https://img.logo.dev/rainbowcrops.com?token=pk_BUpIw_i4QLa-EJtl_XiDng&size=128&format=png&retina=true&fallback=404) Rainbow Crops](https://datahyena.com/companies/rainbow-crops)

## Common questions

 More on Anagram Therapeutics.

 How much funding has Anagram Therapeutics raised? Across the rounds on record with Datahyena, Anagram Therapeutics has $250M in disclosed funding. Some rounds may have undisclosed amounts.
 Who invested in Anagram Therapeutics? Investors on record include Blackstone, Blackstone Life Sciences. Each is resolved to a canonical identity across the rounds that reference it.

## Start pulling signals in minutes.

Create a key, claim your 50 free credits, and make your first request today. No sales call,
 no credit card.

 [Get your API key

→](https://app.datahyena.com/register) [Read the docs](https://datahyena.com/docs)

50 free credits · no credit card